| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Challenges in the clinical assessment of novel tuberculosis drugs
|
Dooley, Kelly E.
|
|
2016
|
102 |
C |
p. 116-122
7 p.
|
artikel
|
| 2 |
Development and delivery of anti-tuberculosis drugs, vaccines and immunotherapeutics
|
Triccas, James A.
|
|
2016
|
102 |
C |
p. 1-2
2 p.
|
artikel
|
| 3 |
Dry powder inhalable formulations for anti-tubercular therapy
|
Parumasivam, Thaigarajan
|
|
2016
|
102 |
C |
p. 83-101
19 p.
|
artikel
|
| 4 |
Editorial Board
|
|
|
2016
|
102 |
C |
p. ii-
1 p.
|
artikel
|
| 5 |
New agents for the treatment of drug-resistant Mycobacterium tuberculosis
|
Hoagland, Daniel T.
|
|
2016
|
102 |
C |
p. 55-72
18 p.
|
artikel
|
| 6 |
Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidates
|
Agger, Else Marie
|
|
2016
|
102 |
C |
p. 73-82
10 p.
|
artikel
|
| 7 |
Potential and development of inhaled RNAi therapeutics for the treatment of pulmonary tuberculosis
|
Man, Dede K.W.
|
|
2016
|
102 |
C |
p. 21-32
12 p.
|
artikel
|
| 8 |
Sharpening nature's tools for efficient tuberculosis control: A review of the potential role and development of host-directed therapies and strategies for targeted respiratory delivery
|
O'Connor, Gemma
|
|
2016
|
102 |
C |
p. 33-54
22 p.
|
artikel
|
| 9 |
Targeted pulmonary delivery of inducers of host macrophage autophagy as a potential host-directed chemotherapy of tuberculosis
|
Gupta, Anuradha
|
|
2016
|
102 |
C |
p. 10-20
11 p.
|
artikel
|
| 10 |
The formulation of nanomedicines for treating tuberculosis
|
Costa, Ana
|
|
2016
|
102 |
C |
p. 102-115
14 p.
|
artikel
|
| 11 |
The global tuberculosis situation and the inexorable rise of drug-resistant disease
|
Marais, Ben J.
|
|
2016
|
102 |
C |
p. 3-9
7 p.
|
artikel
|
Tijdschrift beschrijving